Cost-Effectiveness Analysis of Motixafortide Versus Plerixafor in Stem Cell Mobilization for Autologous Transplantation in Patients with Multiple Myeloma

被引：1
|
作者：
Lamotte, Mark [1 ]
DiPersio, John F. [2 ]
Siegel, David [3 ]
Meron, Haddas [4 ]
Gerlier, Laetitia [1 ]
机构：
[1] IQVIA, Global HEOR, Zaventem, Belgium
[2] Washington Univ, Div Oncol, Internal Med, Sch Med, St Louis, MO USA
[3] Hackensack Univ, John Theurer Canc Ctr, Div Multiple Myeloma, Med Ctr, Hackensack, NJ USA
[4] ModLineRx, Modiin, Israel
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-166865
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10794 / 10795
页数：2
相关论文
共 50 条
  • [21] Plerixafor in myeloma and lymphoma patients undergoing autologous stem cell transplantation
    Zielinska, P.
    Markiewicz, M.
    Helbig, G.
    Mietla, M. Dzierzak
    Yrcz-Krzemien, S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S347 - S347
  • [22] Plerixafor might overcome the detrimental effect of previous autologous stem cell transplantation on haematopoietic stem cell mobilization in myeloma patients
    Basak, G.
    Jaksic, O.
    Mikala, G.
    Koristek, Z.
    Basic-Kinda, S.
    Mayer, J.
    Masszi, T.
    Knopinska-Posluszny, W.
    Giebel, S.
    Labar, B.
    Wiktor-Jedrzejczak, W.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S333 - S334
  • [23] COST-EFFECTIVENESS OF HEMATOPOIETIC STEM CELL MOBILIZATION STRATEGIES IN MULTIPLE MYELOMA AND LYMPHOMA PATIENTS IN CZECH REPUBLIC
    Vitova, V.
    Tichopad, A.
    Sturdikova, M.
    Kucera, Z.
    Lysak, D.
    Koristek, Z.
    VALUE IN HEALTH, 2012, 15 (07) : A513 - A513
  • [24] COST-EFFECTIVENESS OF PLERIXAFOR PLUS GCSF FOR MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH MYELOMA AND LYMPHOMA IN SPAIN
    Duarte, R. F.
    Perez-Simon, J. A.
    Martin, G.
    de la Rubia, J.
    Marin, P.
    Alvarez, M. A.
    Espinos, B.
    Roset, M.
    VALUE IN HEALTH, 2012, 15 (07) : A423 - A423
  • [25] Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells
    Basak, Grzegorz W.
    Jaksic, Ozren
    Koristek, Zdenek
    Mikala, Gabor
    Basic-Kinda, Sandra
    Mayer, Jiri
    Masszi, Tamas
    Giebel, Sebastian
    Labar, Boris
    Wiktor-Jedrzejczak, Wieslaw
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (06) : 488 - 495
  • [26] Impact of Bendamustine Pretreatment on Stem Cell Mobilization and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
    Ponisch, Wolfram
    Wiesler, Julia
    Wagner, Ina
    Leiblein, Sabine
    Edel, Elvira
    Al-Ali, Haifa K.
    Vucinic, Vladan
    Hegenbart, Ute
    Heiss, Christiane
    Niederwieser, Dietger
    Goldschmidt, Hartmut
    BLOOD, 2011, 118 (21) : 842 - 843
  • [27] Plerixafor improves mobilization autologous hematopoietic in stem cell transplantation
    Walter, Monika
    ONKOLOGIE, 2010, 33 (10): : 560 - 563
  • [28] AN EFFECTIVE HEMATOPOIETIC STEM CELL MOBILIZATION ALGORITHM FOR ADDING PLERIXAFOR TO G-CSF FOR MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION
    LaPorte, J.
    Solomon, S.
    Bashey, A.
    Holland, K.
    Morris, L.
    Sizemore, C.
    Sanacore, M.
    Mihelic, R.
    Leech, M.
    Penland, P.
    Xang, Z.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S379 - S380
  • [29] COMPARATIVE COST-EFFECTIVENESS OF PLERIXAFOR PLUS GRANULOCYTE-COLONY STIMULATING FACTOR VERSUS CYCLOPHOSPHAMIDE PLUS GRANULOCYTE-COLONY STIMULATING FACTOR FOR AUTOLOGOUS PERIPHERAL BLOOD STEM CELL MOBILIZATION IN PATIENTS WITH MULTIPLE MYELOMA
    Campen, C. J.
    Yeager, A. M.
    Green, M. R.
    Armstrong, E. P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S349 - S349
  • [30] Efficacy and safety of plerixafor for the mobilization/collection of peripheral hematopoietic stem cells for autologous transplantation in Japanese patients with multiple myeloma
    Ri, Masaki
    Matsue, Kosei
    Sunami, Kazutaka
    Shimazaki, Chihiro
    Hayashi, Akio
    Sunaga, Yoshinori
    Sasaki, Toru
    Suzuki, Kenshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (04) : 562 - 572
12345